Table 1 Clinical and demographic details of the subjects

From: Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer

 

Group 1 surgery only ( n =16)

Group 2 standard chemotherapy ( n =32)

Group 3 anti-VEGF therapy ( n =20)

P -value

Age (years)

71.2 (9.3)

70.9 (7.9)

70.7 (7.9)

0.988

Sex male/female (n)

9/7

18/14

10/10

0.895

BMI (kg m−2)

28.4 (3.1)

27.7 (2.6)

26.2 (2.4)

0.041

Systolic blood pressure (mm Hg)

121 (13)

123 (9)

122 (10)

0.876

Diastolic blood pressure (mm Hg)

74 (8)

75 (10)

74 (7)

0.732

Dukes’ stage (A/B/C/D) (n)

9/5/1/1

2/13/8/9

0/5/11/4

<0.001

Major tumour site (colon/rectum)(n)

12/4

22/10

10/10

0.239

Tumour size (mm)

37 (17)

47 (24)

43 (17)

0.282

Number of nodes excised (n)

10.5 (8.5–12)

12 (8.25–18.7)

11.5 (10.25–18.75)

0.321

  1. Data are mean (s.d.), median (interquartile range), absolute number (n) or percentage. Analysed by ANOVA, Kruskal–Wallis or χ2 as appropriate.
Back to article page